Thibault Boutherin
Stock Analyst at Morgan Stanley
(1.88)
# 3,242
Out of 5,005 analysts
3
Total ratings
100%
Success rate
0.13%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk | Downgrades: Underweight | $59 → $47 | $59.63 | -21.18% | 1 | Sep 29, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Equal-Weight | $10 | $20.01 | -50.02% | 1 | May 25, 2023 | |
| ALVO Alvotech | Initiates: Equal-Weight | $10 | $8.32 | +20.19% | 1 | Sep 7, 2022 |
Novo Nordisk
Sep 29, 2025
Downgrades: Underweight
Price Target: $59 → $47
Current: $59.63
Upside: -21.18%
Teva Pharmaceutical Industries
May 25, 2023
Initiates: Equal-Weight
Price Target: $10
Current: $20.01
Upside: -50.02%
Alvotech
Sep 7, 2022
Initiates: Equal-Weight
Price Target: $10
Current: $8.32
Upside: +20.19%